Questions for my oncology team
These are questions, not recommendations. Nothing on this sheet is advice, and nothing on it was written knowing anything about you.
I am bringing these for somebody else
This sheet is assembled in your browser from the questions you picked, which are held in the address of this page and nowhere else. With JavaScript switched off it cannot be assembled, and every question in the register is still readable on the entry it belongs to, and in the grade table.
Nothing on this page is stored. The list lives in the address bar, so sending that address is how you share it, and closing the tab is how you discard it.
If you are bringing these for someone else
The register has no way of knowing who is reading it, and this section is here on every sheet because the second person in the room is common and is rarely written for. Chapter 24 of the book is addressed to them.
- Ask beforehand which of these they want raised, and raise only those
The person who found the claim is usually the one pushing hardest for it, and the person who is ill is usually the more tired of the two. That combination is how a conversation about somebody's body ends up being driven by somebody else. Asking first, and then raising only what was agreed, is what keeps it theirs.
- Let them answer questions addressed to them, even slowly
A patient who has stopped speaking in their own appointments has lost something that matters more than any item on a list. Waiting through a slow answer is not a wasted minute.
- Write down what is said
This is the one thing a second person can do that needs nobody's permission and costs nothing, and chapter 24 names it as the most valuable. Leaving with an accurate record of what was actually said is worth more than any amount of advocacy, and more than any question on this sheet.
- If they are taking something and have not said so
This is common rather than unusual: across the studies gathered in one review, between a fifth and three quarters of people using a complementary or alternative therapy had not told the person treating them. It is worth knowing, before the subject comes up, that the professional body's own notice asks oncology teams to be proactive and non-judgemental about it, because people usually reach for these things out of a wish for control or for hope. The fear of a telling-off is often the thing keeping the conversation from happening, and it is a fear the people on the other side of the desk have been asked to remove.12
This site does not help one person talk another round. If somebody does not want a question raised, the answer is that it does not get raised. A register that helped a reader overcome the reluctance of the person being treated would be working against the person it exists for.
Sources for this section
Davis EL, Oh B, Butow PN, Mullan BA, Clarke S. Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. The Oncologist 2012;17(11):1475-1481.
ASCO Clinical Notice, May 2026, recommending against ivermectin and fenbendazole for cancer treatment outside of clinical trials. Published by the American Society of Clinical Oncology.